Neuphoria Therapeutics Inc. 10-K Cybersecurity GRC - 2025-09-29

Page last updated on September 29, 2025

Neuphoria Therapeutics Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-09-29 16:46:36 EDT.

Filings

10-K filed on 2025-09-29

Neuphoria Therapeutics Inc. filed a 10-K at 2025-09-29 16:46:36 EDT
Accession Number: 0001193125-25-223338

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity . Risk management and strategy Neuphoria recognizes the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity and availability of our data. Managing Material Risks & Integrated Overall Risk Management Our risk management team has evaluated and addressed cybersecurity risks in alignment with our business objectives and operational needs and have integrated them into our overall risk management system. Engage Third-parties on Risk Management Recognizing the complexity and evolving nature of cybersecurity threats, Neuphoria has and engaged with a range of external experts, including cybersecurity assessors, consultants, advisors, and auditors in evaluating and testing our risk management systems. These partnerships will enable us to leverage specialized knowledge and insights, ensuring our cybersecurity strategies and processes remain at the forefront of industry best practices. Oversee Third-party Risk Because we are aware of the risks associated with third-party service providers, Neuphoria will implement stringent processes to oversee and manage these risks. We will conduct thorough security assessments of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with our cybersecurity standards. Risks from Cybersecurity Threats While we have encountered cybersecurity threats, including a breach of an administrative email account, these challenges have not resulted in the loss of any data, materials, or clinical information, and have not materially impaired our operations or financial standing. Governance Board of Directors Oversight The Audit & Risk Management Committee is central to the Board’s oversight of cybersecurity risks and bears the primary responsibility for this domain. The Audit & Risk Management Committee is composed of board members with diverse expertise including risk management, technology, and finance, equipping them to oversee cybersecurity risks effectively. Risk Management Personnel Our IT Manager is actively involved in assessing, monitoring and managing our cybersecurity risks. He has over 30 years of experience in the field of cybersecurity, and his in-depth knowledge and experience are instrumental in developing and executing our cybersecurity strategies. Monitor Cybersecurity Incidents Our IT Manager implements and oversees processes for the regular monitoring of our information systems, which includes having a well-defined incident response plan. In the event of a cybersecurity incident, we can take immediate actions to mitigate the impact and long-term strategies for remediation and prevention of future incidents. Reporting to Management and the Board of Directors Our IT Manager will provide regular updates to our CEO, Spyros Papapetropoulos, regarding all aspects related to cybersecurity risks and incidents. This ensures that the highest levels of management are kept abreast of the cybersecurity posture and potential risks faced by Neuphoria. Furthermore, significant cybersecurity matters and strategic risk management decisions are escalated to the Board of Directors, ensuring that they have comprehensive oversight and can provide guidance on critical cybersecurity issues. 84


Company Information

NameNeuphoria Therapeutics Inc.
CIK0001191070
SIC DescriptionPharmaceutical Preparations
TickerNEUP - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Emerging growth company
Fiscal Year EndJune 29